We recognize that to realize the promise of precision medicine, we need an entirely new way of thinking about big data. We must be able to quickly and easily bring together massive amounts of information—unstructured as well as structured—and make it readily available for analysis.
We must be able to let the data talk to us, so we can find those valuable correlations and patterns. We need new ways of ensuring security and privacy, so that the diverse stakeholders of the precision medicine megacommunity will freely share data. And we must be able to put the data and analytics directly into the hands of researchers.
These goals are within reach. A new approach to data and analytics—initially developed through an ongoing collaboration between Booz Allen and the U.S. government to combat terrorism and other threats—is now being applied to precision medicine.
